LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Barasertib | 10 | uM | LJP5 | 72 | hr | 513 | 1307 | 10362 | 0.1261 | 0.2403 |
MCF 10A | Vemurafenib | 0.04 | uM | LJP5 | 72 | hr | 513 | 10043 | 10362 | 0.9691 | 0.9853 |
MCF 10A | Vemurafenib | 0.12 | uM | LJP5 | 72 | hr | 513 | 10275 | 10362 | 0.9915 | 0.9960 |
MCF 10A | Vemurafenib | 0.37 | uM | LJP5 | 72 | hr | 513 | 9959 | 10362 | 0.9608 | 0.9814 |
MCF 10A | Vemurafenib | 1.11 | uM | LJP5 | 72 | hr | 513 | 8358 | 10362 | 0.8066 | 0.9032 |
MCF 10A | Vemurafenib | 3.33 | uM | LJP5 | 72 | hr | 513 | 4431 | 10362 | 0.4271 | 0.6410 |
MCF 10A | Vemurafenib | 10 | uM | LJP5 | 72 | hr | 513 | 1903 | 10362 | 0.1836 | 0.3524 |
MCF 10A | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 513 | 10269 | 10362 | 0.9908 | 0.9954 |
MCF 10A | Enzastaurin | 0.12 | uM | LJP5 | 72 | hr | 513 | 10051 | 10362 | 0.9698 | 0.9857 |
MCF 10A | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 513 | 9980 | 10362 | 0.9629 | 0.9825 |
MCF 10A | Enzastaurin | 1.11 | uM | LJP5 | 72 | hr | 513 | 10017 | 10362 | 0.9663 | 0.9838 |
MCF 10A | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 513 | 9146 | 10362 | 0.8823 | 0.9423 |
MCF 10A | Enzastaurin | 10 | uM | LJP5 | 72 | hr | 513 | 7625 | 10362 | 0.7357 | 0.8632 |
MCF 10A | Palbociclib | 0.04 | uM | LJP6 | 72 | hr | 513 | 7760 | 10473 | 0.7410 | 0.8668 |
MCF 10A | Palbociclib | 0.12 | uM | LJP6 | 72 | hr | 513 | 6252 | 10473 | 0.5969 | 0.7762 |
MCF 10A | Palbociclib | 0.37 | uM | LJP6 | 72 | hr | 513 | 4868 | 10473 | 0.4647 | 0.6768 |
MCF 10A | Palbociclib | 1.11 | uM | LJP6 | 72 | hr | 513 | 3769 | 10473 | 0.3599 | 0.5813 |
MCF 10A | Palbociclib | 3.33 | uM | LJP6 | 72 | hr | 513 | 3336 | 10473 | 0.3184 | 0.5371 |
MCF 10A | Palbociclib | 10 | uM | LJP6 | 72 | hr | 513 | 2395 | 10473 | 0.2286 | 0.4244 |
MCF 10A | PF562271 | 0.04 | uM | LJP6 | 72 | hr | 513 | 8702 | 10473 | 0.8310 | 0.9167 |
MCF 10A | PF562271 | 0.12 | uM | LJP6 | 72 | hr | 513 | 7123 | 10473 | 0.6802 | 0.8304 |
MCF 10A | PF562271 | 0.37 | uM | LJP6 | 72 | hr | 513 | 4631 | 10473 | 0.4421 | 0.6568 |
MCF 10A | PF562271 | 1.11 | uM | LJP6 | 72 | hr | 513 | 1722 | 10473 | 0.1644 | 0.3177 |
MCF 10A | PF562271 | 3.33 | uM | LJP6 | 72 | hr | 513 | 668 | 10473 | 0.0638 | 0.0620 |
MCF 10A | PF562271 | 10 | uM | LJP6 | 72 | hr | 513 | 589 | 10473 | 0.0563 | 0.0322 |